Applicability of adipose-derived mesenchymal stem cells in treatment of patients with type 2 diabetes

80Citations
Citations of this article
145Readers
Mendeley users who have this article in their library.

Abstract

Type 2 diabetes mellitus (T2DM) is mainly characterized by insulin resistance (IR) and impaired insulin secretion. The chronic inflammatory process contributed to IR and could also hamper pancreatic β cell function. However, currently applied treatment cannot reverse β cell damage or alleviate inflammation. Mesenchymal stem cells (MSCs), the cell-based therapy for their self-renewable, differentiation potential, and immunosuppressive properties, have been demonstrated in displaying therapeutic effects in T2DM. Adipose-derived MSCs (AD-MSCs) attracted more attention due to less harvested inconvenience and ethical issues commonly accompany with bone marrow-derived MSCs (BM-MSCs) and fetal annex-derived MSCs. Both AD-MSC therapy studies and mechanism explorations in T2DM animals presented that AD-MSCs could translate to clinical application. However, hyperglycemia, hyperinsulinemia, and metabolic disturbance in T2DM are crucial for impairment of AD-MSC function, which may limit the therapeutical effects of MSCs. This review focuses on the outcomes and the molecular mechanisms of MSC therapies in T2DM which light up the hope of AD-MSCs as an innovative strategy to cure T2DM.

References Powered by Scopus

Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors

16733Citations
N/AReaders
Get full text

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement

14593Citations
N/AReaders
Get full text

Induced pluripotent stem cell lines derived from human somatic cells

8769Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Tissue Engineering and Regenerative Medicine: Achievements, Future, and Sustainability in Asia

191Citations
N/AReaders
Get full text

Potential pre-activation strategies for improving therapeutic efficacy of mesenchymal stem cells: current status and future prospects

68Citations
N/AReaders
Get full text

High-efficient generation of VCAM-1<sup>+</sup> mesenchymal stem cells with multidimensional superiorities in signatures and efficacy on aplastic anaemia mice

40Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Qi, Y., Ma, J., Li, S., & Liu, W. (2019). Applicability of adipose-derived mesenchymal stem cells in treatment of patients with type 2 diabetes. Stem Cell Research and Therapy, 10(1). https://doi.org/10.1186/s13287-019-1362-2

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 27

64%

Researcher 11

26%

Lecturer / Post doc 4

10%

Readers' Discipline

Tooltip

Biochemistry, Genetics and Molecular Bi... 22

41%

Medicine and Dentistry 20

37%

Agricultural and Biological Sciences 7

13%

Nursing and Health Professions 5

9%

Save time finding and organizing research with Mendeley

Sign up for free